4basebio says "tier one" partner tests vaccine from its template
(Alliance News) - 4basebio PLC on Monday said its synthetic DNA product has been used in US clinical trials by a "global tier one" pharmaceutical partner. Read More
| Price | 560.00p on 05-02-2026 at 13:25:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 600.00p |
| Sell | 520.00p |
| Last Trade: | Buy 173.00 at 573.22p |
| Day's Volume: | 0 |
| Last Close: | 560.00p |
| Open: | 560.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 560.00p - 560.00p |
| 52wk Range: | 560.00p - 1,200.00p |
| Market Capitalisation: | £86.72m |
| VWAP: | 0.00p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 173 | 573.22p | Ordinary |
14:03:31 - 04-Feb-26 |
| Unknown* | 1,650 | 575.40p | Ordinary |
08:43:28 - 03-Feb-26 |
| Sell* | 70 | 550.00p | Ordinary |
08:17:02 - 02-Feb-26 |
| Buy* | 89 | 600.00p | Ordinary |
08:15:51 - 02-Feb-26 |
| Sell* | 811 | 551.00p | Ordinary |
12:26:11 - 30-Jan-26 |
| Sell* | 11 | 555.00p | Ordinary |
09:42:32 - 30-Jan-26 |
| Buy* | 1 | 577.45p | Ordinary |
08:56:05 - 30-Jan-26 |
| Buy* | 50 | 577.45p | Ordinary |
15:26:08 - 29-Jan-26 |
| Sell* | 41 | 555.00p | Ordinary |
08:04:47 - 29-Jan-26 |
| Unknown* | 1,500 | 550.00p | Ordinary |
16:42:32 - 28-Jan-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
| 22nd Jul 2025 7:00 am | PRN | Employee Long Term Incentive Plan and Issue of Equity |
| 8th Jul 2025 10:30 am | PRN | Director Appointment, Board Change |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 2nd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 2nd Jul 2025 7:00 am | PRN | Holding(s) in Company |